ScanSource, Inc. SCSC
58.30
0.23
0.40%
as of 25 Sep
- Market cap
- $1.2B
- P/E
- 15.7×
Follow SCSC
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
14.08 | 10.90 | 11.87 | 13.49 |
+8 more quarters Free account |
P/S ratio |
0.35 | 0.25 | 0.28 | 0.32 | |
P/FCF ratio |
9.78 | 6.25 | 7.15 | 11.75 | |
P/Operating CF |
(490.27) | 10.84 | 27.69 | 41.73 | |
P/B ratio |
1.22 | 0.85 | 0.94 | 1.06 | |
Price to Tangible BV |
1.85 | 1.30 | 1.44 | 1.55 | |
EV/Sales |
0.35 | 0.24 | 0.29 | 0.33 | |
EV/EBITDA |
9.17 | 6.33 | 7.26 | 7.96 | |
EV/Operating CF |
9.15 | 5.68 | 6.84 | 10.77 | |
EV/FCF |
9.90 | 6.10 | 7.31 | 11.86 | |
Quick Ratio |
1.01 | 1.03 | 1.05 | 1.13 | |
Current Ratio |
1.76 | 1.86 | 1.96 | 2.16 | |
Net Debt/EBITDA |
0.35 | (0.63) | 0.80 | 0.28 | |
Debt/Assets |
5.25% | 5.65% | 5.89% | 7.80% | |
Debt/Equity |
0.11 | 0.11 | 0.11 | 0.15 | |
Asset Turnover |
1.74 | 1.75 | 1.76 | 1.72 | |
Operating CF/Net income |
(0.09) | 4.23 | 1.87 | 1.17 | |
Capex/Depreciation |
(0.43) | (0.41) | (0.31) | (0.38) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
8.57% | 10.18% | 10.19% | 10.18% | |
Intangible Assets out of Total Assets |
0.16 | 0.17 | 0.18 | 0.17 | |
Share Based Compensation of Revenue |
0.37% | 0.52% | 0.48% | 0.39% | |
Graham Net Nets |
0.44 | 0.61 | 0.55 | 0.52 | |
Graham Number |
59.55 | 56.45 | 55.53 | 55.18 | |
Earnings Yield |
7.10% | 9.17% | 8.42% | 7.41% | |
Free Cash Flow Yield |
10.22% | 16.00% | 13.99% | 8.51% | |
Revenue per Share |
44.57 | 35.99 | 35.06 | 33.59 | |
Operating CF per Share |
(0.11) | 3.35 | 1.41 | 1.05 | |
Capex per Share |
(0.12) | (0.11) | (0.09) | (0.11) | |
Free Cash Flow per Share |
(0.22) | 3.24 | 1.32 | 0.95 | |
Cash per Share |
4.13 | 5.65 | 3.82 | 5.67 | |
Shareholders Equity per Share |
42.59 | 42.54 | 41.66 | 41.51 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
42.59 | 42.54 | 41.66 | 41.51 | |
Free Cash Flow |
(4.79) | 68.95 | 28.87 | 20.82 | |
Working Capital |
648.85 | 635.02 | 638.84 | 701.18 | |
Capital Expenditures |
(2.52) | (2.40) | (1.97) | (2.39) | |
Net Current Asset Value |
486.36 | 472.34 | 472.29 | 504.39 | |
EV/EBIT |
11.43 | 8.06 | 9.40 | 10.46 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
2.69% | 2.20% | 2.15% | 2.69% | |
Price to Operating Income |
11.29 | 8.26 | 9.19 | 10.36 | |
| Other line items | |||||
Average Receivables |
709.40 | 600.67 | 582.87 | 562.10 | |
Average Payables |
675.94 | 593.71 | 548.54 | 554.12 | |
Average Inventory |
503.08 | 481.42 | 491.12 | 504.71 | |
Average Assets |
1,859.02 | 1,765.48 | 1,722.10 | 1,751.74 | |
Average Common Equity |
908.60 | 904.00 | 905.77 | 917.46 |
Columns are period end dates